3 registered trials, newest registry update first. Showing only trials linked to AOD-9604.
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain NCT05298306 | AOD-9604 | Phase 1 | Completed | Lateral Pharma Pty Ltd | 26 | May 12, 2023 | Nov 27, 2024 |
| Oral LAT8881 in Neuropathic Pain NCT03865953 | AOD-9604 | Phase 2 | Completed | Lateral Pharma Pty Ltd | 53 | Apr 19, 2020 | Jun 14, 2021 |
| A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine NCT04153409 | AOD-9604 | Phase 2 | Completed | Lateral Pharma Pty Ltd | 21 | Feb 15, 2020 | Apr 28, 2021 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.
